Bioselective Targeting Dextran Bioconjugate Anti-Inflammatory/Immunosuppressant Therapy

Stephen Massia (Inventor)

Research output: Patent

Fingerprint

Dive into the research topics of 'Bioselective Targeting Dextran Bioconjugate Anti-Inflammatory/Immunosuppressant Therapy'. Together they form a unique fingerprint.

Keyphrases

Immunology and Microbiology

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science